133 related articles for article (PubMed ID: 31250729)
1. Genetics of high-dose methotrexate-induced oral mucositis: current perspectives.
Heil SG
Pharmacogenomics; 2019 Jun; 20(9):621-623. PubMed ID: 31250729
[No Abstract] [Full Text] [Related]
2. Genetic markers in methotrexate treatments.
Giletti A; Esperon P
Pharmacogenomics J; 2018 Dec; 18(6):689-703. PubMed ID: 30237581
[TBL] [Abstract][Full Text] [Related]
3. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T
Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of methotrexate in pediatric hematological neoplasm treatment: does it need a personalized regimen based on MTHFR polymorphisms?
D'Angelo V; Ramaglia M; Iannotta A; Addeo R
Expert Rev Hematol; 2014 Oct; 7(5):517-9. PubMed ID: 25213457
[No Abstract] [Full Text] [Related]
5. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
[TBL] [Abstract][Full Text] [Related]
6. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.
Lambrecht L; Sleurs C; Labarque V; Dhooge C; Laenen A; Sinnaeve F; Renard M; Uyttebroeck A
Pharmacogenomics; 2017 Jun; 18(8):787-795. PubMed ID: 28592186
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation.
Robien K; Schubert MM; Chay T; Bigler J; Storb R; Yasui Y; Potter JD; Ulrich CM
Bone Marrow Transplant; 2006 Apr; 37(8):799-800. PubMed ID: 16501586
[No Abstract] [Full Text] [Related]
8. Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
Oosterom N; Griffioen PH; den Hoed MAH; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
PLoS One; 2018; 13(7):e0199574. PubMed ID: 29985926
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients.
Dogan M; Karabulut HG; Tukun A; Demirkazik A; Utkan G; Yalcin B; Dincol D; Akbulut H; Icli F
Asian Pac J Cancer Prev; 2012; 13(4):1553-6. PubMed ID: 22799365
[TBL] [Abstract][Full Text] [Related]
10. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.
Gutierrez-Camino A; Oosterom N; den Hoed MAH; Lopez-Lopez E; Martin-Guerrero I; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; Heil SG; García-Orad A; van den Heuvel-Eibrink MM
Pharmacogenet Genomics; 2017 Aug; 27(8):303-306. PubMed ID: 28628559
[TBL] [Abstract][Full Text] [Related]
11. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico.
Ruiz-Argüelles GJ; Coconi-Linares LN; Garcés-Eisele J; Reyes-Núñez V
Hematology; 2007 Oct; 12(5):387-91. PubMed ID: 17891601
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival.
Gemmati D; Ongaro A; Tognazzo S; Catozzi L; Federici F; Mauro E; Della Porta M; Campioni D; Bardi A; Gilli G; Pellati A; Caruso A; Scapoli GL; De Mattei M
Haematologica; 2007 Apr; 92(4):478-85. PubMed ID: 17488658
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
Giletti A; Vital M; Lorenzo M; Cardozo P; Borelli G; Gabus R; Martínez L; Díaz L; Assar R; Rodriguez MN; Esperón P
Eur J Pharm Sci; 2017 Nov; 109():480-485. PubMed ID: 28887233
[TBL] [Abstract][Full Text] [Related]
15. MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis.
Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Ongaro A
Pharmacogenomics; 2016 Jun; 17(9):1005-17. PubMed ID: 27270164
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.
Campbell JM; Bateman E; Stephenson MD; Bowen JM; Keefe DM; Peters MD
Cancer Chemother Pharmacol; 2016 Jul; 78(1):27-39. PubMed ID: 27142726
[TBL] [Abstract][Full Text] [Related]
17. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
[TBL] [Abstract][Full Text] [Related]
18. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Samejima H; Sato R; Shimada H; Yahagi N; Torii C; Yoshihara H; Tanigawara Y; Takahashi T; Kosaki K
J Pediatr Hematol Oncol; 2006 Feb; 28(2):64-8. PubMed ID: 16462575
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic study of 5,10-methylenetetrahydrofolate reductase C677T and thymidylate synthase 3R/2R gene polymorphisms and methotrexate-related toxicity in Chinese Han patients with inflammatory arthritis.
Zeng QY; Wang YK; Xiao ZY; Chen SB
Ann Rheum Dis; 2008 Aug; 67(8):1193-4. PubMed ID: 18621970
[No Abstract] [Full Text] [Related]
20. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
Turello R; Rentsch K; Di Paolo E; Popovic MB
Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]